HLN Blogs
Read our insights about what is going on in Health IT
ONC Tech Forum 2020: An Attendee’s Perspective
HLN attended the ONC summer Tech Forum in August 2020 which brought together over 1,500 industry experts and Federal partners to discuss technical innovations in health information technology and their potential impacts on the healthcare ecosystem.
Read more >
HLN Participates in NACCHO 360 Virtual Conference
Dr. Noam Arzt, President of HLN, recorded a session for the NACCHO360 Virtual Conference available during the week of July 6 for registered attendees in the Information and Technology track. Titled, “Interoperability Update for Public Health: What’s In Store for the Coming Decade,” this talk reviews major developments in healthcare interoperability that will affect public health over the coming years.
Read more >
ONC Releases Pediatric Health IT Developer Informational Resources
The primary purpose of the guide is to assist electronic health record (EHR) software developers in improving their products to better support pediatric health requirements.
Read more >
Case Reporting and COVID-19: Open Source Solutions
As people begin to spend more time together again, it is critically important that public health agencies do everything they can to help prevent further spread of the infection and continue to monitor the level of infection within the population. A national project has been underway to implement electronic case reporting (eCR).
Read more >
Senate White Paper: Preparing for the Next Pandemic
On June 10, 2020 the US Senate released a white paper titled “Preparing for the Next Pandemic” under the signature of Senator Lamar Alexander of Tennessee. The white paper has five recommendations to address future pandemics based on lessons learned from COVID-19 and the past 20 years of pandemic planning.
Read more >
Leveraging the ICE Open Source Immunization Forecaster during COVID-19
Like many things in the age of COVID-19, the vaccine development landscape is unlike anything we have seen in our lifetimes. There are over 100 SARS-CoV-2 vaccines currently in development, many of which are utilizing new technologies not used in any currently licensed vaccine. The potential impact on immunization schedules (clinical guidelines for clinicians) and immunization clinical decision support is significant.
Read more >